ALC:NYSE
Alcon AG
73,64 $
arrow_downward
−0,66%(−0,49) 1 p
73,64 $
0,00% (0,00)
bedtimePärast tööaega
Suletud: 16. nov, 16:00:05 GMT −5 · USD
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse ALC põhistatistika genereerimine…
Ava
74,35 $
Kõrge
74,76 $
Madal
73,50 $
Turu kapit.
31,19 mld
Keskm. maht
2,14 mln
Maht
1,77 mln
52 näd kõrgeim
87,64 $
52 näd madalaim
61,84 $
Beeta
0,87
Käibivad aktsiad
483,40 mln
Töötajate arv
25 tuh
Ava
74,35 $
Kõrge
74,76 $
Madal
73,50 $
Turu kapit.
31,19 mld
Keskm. maht
2,14 mln
Maht
1,77 mln
52 näd kõrgeim
87,64 $
52 näd madalaim
61,84 $
Beeta
0,87
Käibivad aktsiad
483,40 mln
Töötajate arv
25 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
TradingView
·
1 tunni eest
Dow, S&P 500, Nasdaq Futures Mixed Ahead Of Much-Anticipated Nvidia Earnings, Anthropic IPO: SLS, BABA, JPM, OMER In Focus
ChartMill
·
9 tunni eest
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
The Motley Fool
·
14 tunni eest
Is an Equal-Weight S&P 500 Fund Safer Right Now Than the One You Own?
Traders Union
·
6 tunni eest
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
Profiil
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Teave üksuse Alcon AG kohta
TegevjuhtDavid J. Endicott
Töötajad25 tuh
Asutatud1945
PeakontoridGenf, Genf, Šveits
SektorHealth Care
Valdkond-
Veebisaitalcon.com